At Mabqi, we have developed the LiteMab© Antibody Discovery studio to find the « perfect » antibodies that binds with high specificity to complex, low-expression targets, readily developable and functional.
LiteMab platform is specifically designed to tackle high-difficulty discoveries.
Our versatile platform excels in addressing complex programs by seamlessly integrating multiple requirements. This adaptability allows us to tackle a wide array of specifications, including:
For each target of interest, we perform customized antibody screening programs using our suite of synthetic human antibodies libraries and highly innovative, flexible and robust discovery workflows.
Our expert team provides comprehensive solutions for antibody discovery and development programs, delivering seamless support across the entire discovery workflow.
1. Optimal antibody selection strategies:
2. Comprehensive antibody hits’ characterization:
Comprehensive binding affinity evaluation for soluble and membrane-bound targets, EC50 binding potency assessment, cell-based flow cytometry assay to determine the binding potency based on cell line expression, epitope specificity, cross-reactivity, …
3. Rigorous functional validation processes: internalization assays, direct cytotoxicity assays, ….
Looking for a partner?
If you’re working on challenging targets, advanced modalities and need a specialized discovery partner, Let’s connect!
